Trials / Sponsors / Faeth Therapeutics
Faeth Therapeutics
Industry · 5 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patie Endometrial Cancer | Phase 2 | 2024-12-12 |
| Terminated | A Study of Sapanisertib in Relapsed/Refractory NFE2L2-Mutated and Wild-Type Squamous Non-Small Cell Lung Cance Non-Small Cell Lung Cancer, Squamous Non-small-cell Lung Cancer, Squamous Non-Small Cell Neoplasm of Lung | Phase 2 | 2022-07-21 |
| Withdrawn | Medical Food for the Dietary Management of Metastatic Colorectal Cancer Metastatic Colorectal Cancer | N/A | 2022-04-27 |
| Completed | Combination of Serabelisib and Insulin Suppressing Diet With or Without Nab-paclitaxel in Subjects With Advanc Advanced Solid Tumor, PIK3CA Mutation, PTEN Loss of Function Mutation | Phase 1 | 2022-04-22 |
| Completed | Medical Food for the Dietary Management of Advanced/Metastatic Pancreatic Cancer Metastatic Pancreatic Adenocarcinoma, Locally Advanced Unresectable Pancreatic Adenocarcinoma | N/A | 2021-12-21 |